Presentation is loading. Please wait.

Presentation is loading. Please wait.

Clinical, biologic, and pathologic features in 157 patients with angioimmunoblastic T-cell lymphoma treated within the Groupe d'Etude des Lymphomes de.

Similar presentations


Presentation on theme: "Clinical, biologic, and pathologic features in 157 patients with angioimmunoblastic T-cell lymphoma treated within the Groupe d'Etude des Lymphomes de."— Presentation transcript:

1 Clinical, biologic, and pathologic features in 157 patients with angioimmunoblastic T-cell lymphoma treated within the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trials by Nathalie Mourad, Nicolas Mounier, Josette Brière, Emmanuel Raffoux, Alain Delmer, Alfred Feller, Chris J. L. M. Meijer, Jean-François Emile, Réda Bouabdallah, André Bosly, Jacques Diebold, Corinne Haioun, Bertrand Coiffier, Christian Gisselbrecht, and Philippe Gaulard Blood Volume 111(9): May 1, 2008 ©2008 by American Society of Hematology

2 Histopathologic spectrum of AITL and patterns of CXCL13 expression. Nathalie Mourad et al. Blood 2008;111: ©2008 by American Society of Hematology

3 Survival of the 156 patients with angioimmunoblastic T-cell lymphoma. Nathalie Mourad et al. Blood 2008;111: ©2008 by American Society of Hematology

4 Overall survival of angioimmunoblastic T-cell lymphoma patients. Nathalie Mourad et al. Blood 2008;111: ©2008 by American Society of Hematology


Download ppt "Clinical, biologic, and pathologic features in 157 patients with angioimmunoblastic T-cell lymphoma treated within the Groupe d'Etude des Lymphomes de."

Similar presentations


Ads by Google